Details

Latest COVID-19 prevention and control plan announced: Inbound travelers' quarantine changed to 7 days isolation and 3 days home monitoring.


06-28

To further guide local areas in their COVID-19 prevention and control work, based on the practical experience of prevention and control work since the release of the "COVID-19 Prevention and Control Scheme (Eighth Edition)", and especially in light of the characteristics of the Omicron variant, such as its rapid spread and strong concealment, the State Council's Joint Prevention and Control Mechanism for the COVID-19 Epidemic has revised the "COVID-19 Prevention and Control Scheme (Ninth Edition)" to comprehensively implement the overall strategy of "preventing imported cases and rebounding cases within the country" and the overall approach of "dynamic zero-COVID", effectively safeguarding the lives and health of the people, and coordinating epidemic prevention and control with economic and social development to the greatest extent possible. The main revisions compared to the eighth edition include:
I. Optimization and Adjustment of the Isolation Management Period and Methods for High-Risk Personnel
The isolation and control time for close contacts and inbound personnel is adjusted from "14 days of centralized isolation medical observation + 7 days of home health monitoring" to "7 days of centralized isolation medical observation + 3 days of home health monitoring" The nucleic acid testing measures are adjusted from "nucleic acid testing on days 1, 4, 7, and 14 of centralized isolation medical observation, collecting nasopharyngeal swabs, and double sampling and double testing before release from isolation" to "Nucleic acid testing on days 1, 2, 3, 5, and 7 of centralized isolation medical observation and on day 3 of home health monitoring, collecting oropharyngeal swabs" Double sampling and double testing are not required before release from centralized isolation medical observation. The control measures for close contacts of close contacts are adjusted from "7 days of centralized isolation medical observation" to "7 days of home isolation medical observation", with nucleic acid testing on days 1, 4, and 7.
II. Unified Standards for Defining Lockdown and Control Areas and High and Medium-Risk Areas
The standards and prevention and control measures for the two types of risk areas are aligned and unified, using the concept of high and medium-risk areas, forming a new risk area delineation and control plan. High-risk areas implement "no entry or exit, door-to-door service"; they are downgraded to medium-risk areas after 7 consecutive days with no new infections. Medium-risk areas are downgraded to low-risk areas after 3 consecutive days with no new infections. In other areas, those with a travel history to high-risk areas within the past 7 days will undergo 7 days of centralized isolation medical observation. Medium-risk areas implement "no entry or exit from the area, staggered collection of items"; they are downgraded to low-risk areas after 7 consecutive days with no new infections. In other areas, those with a travel history to medium-risk areas within the past 7 days will undergo 7 days of home medical observation. Low-risk areas refer to other areas in the county (city, district, banner) where medium- and high-risk areas are located, implementing "personal protection, avoiding gatherings". In other areas, those with a travel history to low-risk areas within the past 7 days are required to complete 2 nucleic acid tests within 3 days.
III. Improvement of Epidemic Monitoring Requirements
The frequency of nucleic acid testing for high-risk occupational groups is increased. Nucleic acid testing for personnel directly in contact with inbound personnel, goods, and the environment is adjusted to once a day, and nucleic acid testing for personnel in high-density, frequent contact, and high-mobility industries is adjusted to twice a week. Antigen testing is added as a supplementary means of epidemic monitoring. Primary-level medical and health institutions can increase antigen testing for suspected patients and for personnel in high- and medium-risk areas during epidemic response.
IV. Optimization of Regional Nucleic Acid Testing Strategies
Clarification of nucleic acid testing plans for different population sizes. For provincial capital cities and cities with a population of over 10 million, general cities, and rural areas, a judgment is made based on factors such as whether the source of infection is clear after an outbreak, whether there is a risk of community transmission, and whether the transmission chain is clear. Based on the level of risk, the scope and frequency of regional nucleic acid testing are determined according to the principle of graded classification.

News Source | CCTV News